Park Hotels & Resorts carries an implied valuation below the per-key prices it's realizing on dispositions, and 11 analysts still can't find a reason to upgrade. Truist held its rating. Wells Fargo just dropped its target to $10. The average target across the coverage universe sits between $11 and $12, implying single-digit upside from current levels. That's not conviction. That's a polite way of saying "we're watching."

The Q4 2025 numbers explain the hesitation. Comparable RevPAR of $182.49, up 0.8% year-over-year. Strip out the Royal Palm drag and you get 2.8%. Core RevPAR tells a slightly better story at $210.15, up 3.2% (5.7% ex-Royal Palm). But the bottom line was a $204 million net loss on $248 million in impairments. Full-year net loss: $277 million on $318 million in impairments. Adjusted EBITDA of $609 million looks respectable until you run it against the capital deployed. The company spent nearly $300 million on improvements and sold $132 million in non-core assets in 2025. That's a portfolio in transition, not a portfolio generating returns.

Here's what the "hold" consensus is actually pricing. Park's strategy is correct on paper: sell low-performing assets, reinvest in premium-branded properties in top markets, strengthen the balance sheet. The San Francisco exits were necessary surgery. The Hawaii and Orlando concentration makes strategic sense for a leisure-weighted recovery thesis. But strategy and execution operate on different timelines. The impairments tell you the legacy portfolio was marked above where the market would transact. The RevPAR growth tells you the retained assets aren't yet producing enough incremental NOI to offset what's being sold or written down. The $45 million in share repurchases during Q1 2025 is a signal that management believes the stock is cheap... but the market is disagreeing, and the market has been right longer than management has been buying.

The structural problem for Park is duration. Portfolio transformation at this scale takes three to five years. Investors pricing lodging REITs today want to see current yield and near-term NOI growth, not a story about what the portfolio looks like in 2029. A company reporting $277 million in annual net losses while spending $300 million on CapEx is asking shareholders to fund the transition. That's a reasonable ask if you believe the terminal portfolio justifies the investment. The analyst consensus suggests most of Wall Street isn't there yet.

One ratio I keep coming back to: $609 million in adjusted EBITDA against a market cap that's been hovering in the low-to-mid single-digit billions. The implied multiple is compressed, which either means the market is wrong about the asset quality (possible) or right about the earnings trajectory (more likely in the near term). When I was on the asset management side, we had a portfolio going through a similar repositioning. The math always looked better on the three-year model than on the trailing twelve months. The problem is you don't get to live in the three-year model. You live in the quarters.

Xenia posted $0.45 in Adjusted FFO per diluted share for Q4 2025, a 15.4% year-over-year increase on $265.6 million in revenue. The Street expected $0.04 EPS. They delivered $0.07. Same-Property RevPAR grew 4.5% to $176.45. None of that is the interesting number.

The interesting number is 44%. That's non-rooms revenue as a share of total revenue. Food and beverage alone grew 13.4% for the full year. In an industry where most lodging REITs generate 70-80% of revenue from rooms, Xenia is running a fundamentally different mix. A 44% non-rooms contribution means the per-occupied-room economics look nothing like a typical upper-upscale portfolio. It also means the cost structure looks nothing like one. F&B at 13.4% growth requires bodies... servers, cooks, banquet staff. Wages and benefits are guided to grow roughly 6% in 2026. That's the tension hiding inside an otherwise clean earnings print.

The 2026 guide tells the real story. Same-Property RevPAR growth of 1.5% to 4.5% against a 4.5% increase in operating expenses. At the midpoint, that's 3% RevPAR growth versus 4.5% expense growth. Run the flow-through math on that spread and you get margin compression unless non-rooms revenue fills the gap. Management is explicitly betting it will. Adjusted FFO per share is guided to $1.89 at the midpoint, roughly 7% above 2025. That 7% FFO growth on 3% RevPAR growth implies the non-rooms engine does all the heavy lifting. It's a plausible thesis. It's also a thesis that breaks if group demand softens or if F&B labor costs accelerate past 6%.

Capital allocation is where the discipline shows. The Fairmont Dallas disposition at $111 million avoided an estimated $80 million in near-term CapEx and generated an 11.3% unlevered IRR. That's a sell decision that most REITs wouldn't make because the asset looks fine on a trailing NOI basis. But trailing NOI doesn't capture the CapEx cliff. Xenia looked at the forward capital requirement, compared it to the disposition proceeds, and chose liquidity. They also repurchased 9.4 million shares at a weighted-average price of $12.87 while the stock now trades near $16. The buyback math works (so far). The $25 million land acquisition under the Hyatt Regency Santa Clara to eliminate lease renewal risk is the kind of quiet, unsexy move that adds real long-term value and never makes a headline.

One thing to watch. Director Barry Bloom sold 151,909 shares on February 26 at $15.73, reducing his position by 90.89%. Insider sales have a thousand innocent explanations (diversification, tax planning, estate planning). A 91% reduction in position two days after an earnings beat has fewer innocent explanations than a 10% trim. I'm not drawing a conclusion. I'm noting the data point. Check again when Q1 results hit May 1.

CLDT posted $0.21 AFFO per diluted share against a consensus estimate of negative $0.12. That's a $0.33 beat on a stock trading under $8. Revenue came in at $67.7 million, roughly $900K below estimate, while RevPAR declined 1.8% to $131 across 33 comparable hotels. The headline says "exceeds expectations." The real number says this is a cost story, not a revenue story.

Let's decompose the margin picture. GOP margins declined only 30 basis points to 40.2% despite the RevPAR erosion. Hotel EBITDA margins actually improved 70 basis points to 33.2%. Labor and benefits grew less than 3% on a cost-per-occupied-room basis. ADR fell 0.9% to $179, occupancy slipped 70 basis points to 73%, and somehow the company turned a $4 million net loss in Q4 2024 into $3 million of net income. That's not revenue management. That's expense discipline buying time while the portfolio gets restructured.

The portfolio restructuring is the part worth paying attention to. Chatham sold six older hotels over the past 18 months for approximately $100 million. Those properties had hotel EBITDA margins of 27%. Then on March 4, the company announced the acquisition of six Hilton-branded hotels (589 keys, predominantly extended-stay) for $92 million generating $10 million of hotel EBITDA at 42% margins. That's $156K per key for a portfolio averaging 10 years of age. The math on the swap: roughly $8 million less in proceeds than what they sold, but the acquired EBITDA margins are 15 percentage points higher. They're trading older, lower-margin assets in presumably weaker markets for newer extended-stay product in secondary markets. The 2025 EBITDA on the acquired portfolio implies a 10.9% cap rate on purchase price. At 6.2% average cost of debt, the spread is workable.

The capital allocation tells you where management's head is. They bought back 1.3 million shares in 2025 at an average of $6.83 (the stock is still in that range). They bumped the dividend 11% to $0.40 annualized, which at current prices yields roughly 5%. Total debt is $343 million at 6.2%, leverage ratio down to 20% from 23% a year ago. The 2026 CapEx budget is $26 million, $17 million of it earmarked for renovations at three properties. Management is guiding 2026 RevPAR at negative 0.5% to positive 1.5% and adjusted FFO of $1.04 to $1.14 per share. That guidance range is conservative enough to be credible... which is more than I can say for most REIT outlooks right now.

The question nobody's asking: how long does the cost discipline hold? Labor grew under 3% per occupied room this quarter, partly aided by property tax refunds. That's not a structural improvement. That's a quarter. Extended-stay product helps (lower labor intensity per dollar of revenue is the whole thesis), but Chatham is still a 39-property portfolio concentrated in markets like Silicon Valley, coastal New England, and now a handful of secondary Midwest cities. The asset swap improves the margin profile. It doesn't insulate them from a demand downturn. If RevPAR stays negative through H1 2026, the $0.33 FFO beat becomes a memory and the 6.2% cost of debt becomes the number that matters.

Sunstone posted $0.02 non-GAAP EPS against a consensus estimate of negative $0.015. Revenue hit $236.97M versus the $223.36M forecast. Total portfolio RevPAR climbed 9.6% to $220.12 on a $319 ADR at 69% occupancy. Adjusted EBITDAre grew 17.6% to $56.6M. By every backward-looking metric, this was a clean quarter.

The stock dropped 3.5% in pre-market the morning of the print. Over the trailing twelve months, SHO is down 7% while the S&P 500 is up 21%. That's a 28-point performance gap for a company that just beat on every line. The real number here is that gap. It tells you institutional investors are pricing in margin compression that hasn't shown up in the financials yet. The 2026 guide of $225M-$250M Adjusted EBITDAre and $0.81-$0.94 FFO per share is a wide range... $25M of EBITDAre spread means management isn't sure either. When the range is that wide, I read the bottom.

The capital allocation story is more interesting than the operating story. $108M in buybacks at $8.83 average, a newly reauthorized $500M repurchase program, and a $0.09 quarterly dividend. Sunstone is telling you the stock is cheap (the buybacks prove they believe it). They sold the New Orleans St. Charles for $47M and poured $103M into renovations, primarily the Andaz Miami Beach conversion and room refreshes in Wailea and San Antonio. The Andaz transformation alone contributed 540 basis points to rooms RevPAR. Strip that one asset out and portfolio RevPAR growth looks closer to 4-5%... which, not coincidentally, is the bottom of their 2026 growth guide. One asset is doing a lot of heavy lifting.

The balance sheet is genuinely clean. $185.7M cash, $700M+ total liquidity, no maturities through 2028, 3.5x net leverage. That's a company positioned to acquire if pricing gets distressed or continue buying back stock if it doesn't. The Rush Island stake sale in February (3.7M shares, $34.75M) is worth noting... not because one fund exiting changes the thesis, but because it adds supply to a stock already underperforming its peer group. More shares looking for a home in a name that institutions are already underweight.

The math works for Sunstone at the corporate level. The question is what "works" means when your growth story concentrates in one Miami Beach conversion and your forward guide essentially says "somewhere between fine and pretty good." I've analyzed portfolios where a single asset transformation masked softening across the rest of the book. It reads beautifully in the quarterly deck. It reads differently when the comp normalizes in year two and the other 14 assets need to carry the growth. That's the 2027 question nobody on the earnings call asked.

Citigroup cut 362,632 shares of RLJ Lodging Trust in Q3, a 56% reduction that left it holding $2.05 million in stock. That's 0.17% of a company with a $1.2 billion market cap. Let's be honest about scale: this is not Citi making a dramatic call on lodging REITs. This is Citi cleaning out a position that barely registered on its book.

The real number is RLJ's full-year 2025 net income to common shareholders: $3.4 million. Down from $42.9 million in 2024. That's a 92% decline. On a portfolio of premium-branded, focused-service hotels in major urban markets. Q4 comparable RevPAR fell 1.5% year-over-year to $136.79. The company beat adjusted FFO estimates ($0.32 vs. $0.28 expected), which tells you the Street's expectations were already low. Beating a low bar is not a thesis.

Let's decompose the owner's return here. RLJ carries $2.2 billion in debt at a weighted average rate of 4.6%. That's roughly $101 million in annual interest expense against $3.4 million in net income. The refinancing completed in February 2026 extended maturities through 2028, which removes near-term default risk but doesn't change the fundamental math: this portfolio is servicing debt, not generating equity returns. The 7.6% dividend yield at $7.87 per share looks attractive until you ask how long a company earning $3.4 million can sustain distributions that imply a significantly higher payout. Check again.

What's instructive is the divergence in institutional behavior. JPMorgan increased its position by 4.5% in the same quarter Citi was selling. Vanguard holds 13.5%. BlackRock holds 11.2%. Institutional ownership sits at 92.35%. These are not dumb holders. They see the 2026 guidance (0.5%-3% RevPAR growth, $1.21-$1.41 adjusted FFO per share) and they're making a bet that the cycle turns. Maybe it does. But 0.5% RevPAR growth on the low end, against expense inflation that RLJ itself called "choppy," means margin compression is the base case for owners. Revenue growth without margin improvement is a treadmill (I've audited this exact dynamic at three different REITs... the top line moves, the bottom line doesn't, and the management company still collects its fee).

Analysts have a consensus "Hold" with an $8.64 target. That's 16% upside from $7.43. In a sector trading near historic lows with 92% institutional ownership, the question isn't whether RLJ survives. It's whether the owner's actual return... after management fees, franchise fees, FF&E reserves, CapEx, and debt service... justifies holding the equity at these levels. The math works if you believe the cycle inflects in late 2026. If it doesn't, $3.4 million in net income on a $1.2 billion market cap is a 0.28% return on equity. That's not a lodging investment. That's a parking lot for capital waiting for something better.

$3.17 million across 202,508 shares at a weighted average of $15.63-$15.73. That's what Xenia Hotels' President and COO Barry Bloom sold on February 25 and 26, leaving him with 15,233 shares of direct ownership. Down from 217,741. A 93% reduction.

The timing is the story. On February 24, Xenia reported Q4 adjusted EPS of $0.45 against a $0.04 consensus estimate. Revenue came in at $265.6 million, marginally above expectations. Management issued 2026 FFO guidance of $1.78 to $1.99 per diluted share, midpoint above the Street. The company highlighted strong group demand, active capital improvement, and... external acquisition appetite. One day later, the COO started selling. Two days later, he was nearly out.

Let's decompose what "nearly out" means. Bloom received 27,534 LTIP units on February 24 (the same day as earnings), vesting in thirds across 2027-2029. So the equity compensation pipeline isn't empty. But the liquid, unrestricted position is effectively gone. An executive who keeps his vesting schedule but liquidates his open holdings is making a specific statement about near-term price expectations versus long-term employment. Those are two different bets (and he's only making one of them with his own money).

I've audited insider transaction patterns at three different REITs. The pattern that matters isn't whether an executive sells. Executives sell. They have mortgages, taxes, diversification needs. The pattern that matters is velocity and magnitude relative to holdings. Selling 5-10% after a lockup? Normal. Selling 93% of your direct position in 48 hours, timed to a post-earnings window? That's a data point worth pricing in. Xenia repurchased 2.7 million shares for $36.6 million in Q4 2025... the company is buying while the COO is selling. Same stock, opposite conclusions.

XHR trades around $15.70 with analyst targets ranging from $14.00 to $17.00 and a consensus that's drifted from "buy" to "hold." The PEG ratio sits at 0.19, which looks cheap until you check the FFO volatility that's been flagged by multiple analysts. A 30-property luxury and upper-upscale portfolio across 14 states, and the stock has traded in a $14-$17 band for months. The COO just priced his exit at the top half of that range. If you're an XHR shareholder or an asset manager benchmarking lodging REIT exposure, the question isn't whether this sale is legal (it is) or routine (the filing says it is). The question is whether the person running daily operations at a 30-property REIT just told you something the guidance deck didn't.